Applicant, as named in the Orange Book

Valeant Pharms Intl

Bausch Health Companies Inc · NYSE: BHC

Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings

Next listed expiry: Colazal on 24 Feb 2027. 1 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Colazal NDA 020610 balsalazide disodium	balsalazide disodium	24 Feb 2027 patent	patent

Colazal · Enters 12-month window basis: patentListed date 24 Feb 2027Detected 24 Oct 2026

Products without listed protection (1)

Drug	Ingredient	Earliest generic entry	Basis
Cuprimine NDA 019853 penicillamine	penicillamine	open now no listed protection	no listed protection